Gregory Locke

556 total citations
12 papers, 253 citations indexed

About

Gregory Locke is a scholar working on Molecular Biology, Oncology and Clinical Biochemistry. According to data from OpenAlex, Gregory Locke has authored 12 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Clinical Biochemistry. Recurrent topics in Gregory Locke's work include Metabolism and Genetic Disorders (4 papers), CAR-T cell therapy research (2 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). Gregory Locke is often cited by papers focused on Metabolism and Genetic Disorders (4 papers), CAR-T cell therapy research (2 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). Gregory Locke collaborates with scholars based in United States, Australia and Sweden. Gregory Locke's co-authors include Jovita Marcinkeviciene, Lisa M. Kopcho, Wenjun Jiang, Robert A. Copeland, Mark R. Harpel, Aiying Wang, Charles R. Dorso, Lawrence G. Hamann, Ying Luo and Robert A. Langish and has published in prestigious journals such as Biochemistry, Methods in enzymology on CD-ROM/Methods in enzymology and Archives of Biochemistry and Biophysics.

In The Last Decade

Gregory Locke

12 papers receiving 247 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory Locke United States 9 139 59 50 35 27 12 253
Palani Kirubakaran India 12 262 1.9× 80 1.4× 58 1.2× 14 0.4× 38 1.4× 22 416
Galina Bernstein United States 5 252 1.8× 58 1.0× 67 1.3× 22 0.6× 20 0.7× 5 391
Hazel Corradi United Kingdom 8 323 2.3× 81 1.4× 52 1.0× 28 0.8× 20 0.7× 12 442
Khairul Bariyyah Abd Halim Malaysia 10 193 1.4× 60 1.0× 37 0.7× 10 0.3× 11 0.4× 19 353
Adrien Herlédan France 12 260 1.9× 63 1.1× 50 1.0× 21 0.6× 55 2.0× 21 441
Jianxin Cheng China 13 262 1.9× 72 1.2× 71 1.4× 14 0.4× 66 2.4× 37 423
Alison Leed United States 7 179 1.3× 52 0.9× 41 0.8× 19 0.5× 7 0.3× 8 424
V.L. Linhard Germany 9 179 1.3× 81 1.4× 21 0.4× 9 0.3× 55 2.0× 17 283
Giuseppe Punzi Italy 11 241 1.7× 29 0.5× 22 0.4× 10 0.3× 22 0.8× 14 362
Huan‐Yi Tseng Taiwan 8 139 1.0× 77 1.3× 57 1.1× 32 0.9× 50 1.9× 10 355

Countries citing papers authored by Gregory Locke

Since Specialization
Citations

This map shows the geographic impact of Gregory Locke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Locke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Locke more than expected).

Fields of papers citing papers by Gregory Locke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Locke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Locke. The network helps show where Gregory Locke may publish in the future.

Co-authorship network of co-authors of Gregory Locke

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Locke. A scholar is included among the top collaborators of Gregory Locke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Locke. Gregory Locke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Locke, Gregory, J.K. Muckelbauer, John S. Tokarski, et al.. (2022). Identification and characterization of TYK2 pseudokinase domain stabilizers that allosterically inhibit TYK2 signaling. Methods in enzymology on CD-ROM/Methods in enzymology. 667. 685–727. 3 indexed citations
2.
Halpern, Otto, Javed Khan, Gregory Locke, et al.. (2021). Small molecule and macrocyclic pyrazole derived inhibitors of myeloperoxidase (MPO). Bioorganic & Medicinal Chemistry Letters. 42. 128010–128010. 8 indexed citations
3.
Degnan, Andrew P., Walter L. Johnson, Kurt Zimmermann, et al.. (2021). Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1. ACS Medicinal Chemistry Letters. 12(3). 443–450. 36 indexed citations
4.
Meng, Wei, Leonard P. Adam, Kamelia Behnia, et al.. (2019). Benzothiazole-based compounds as potent endothelial lipase inhibitors. Bioorganic & Medicinal Chemistry Letters. 29(20). 126673–126673. 4 indexed citations
5.
Vasta, James D., Gregory Locke, Mark A. Pattoli, et al.. (2019). A High-Throughput BRET Cellular Target Engagement Assay Links Biochemical to Cellular Activity for Bruton’s Tyrosine Kinase. SLAS DISCOVERY. 25(2). 176–185. 9 indexed citations
6.
Wurtz, Nicholas R., Andrew Q. Viet, Scott A. Shaw, et al.. (2018). Potent Triazolopyridine Myeloperoxidase Inhibitors. ACS Medicinal Chemistry Letters. 9(12). 1175–1180. 19 indexed citations
7.
8.
Locke, Gregory, Dong Cheng, Mark R. Witmer, et al.. (2008). Differential activation of recombinant human acetyl-CoA carboxylases 1 and 2 by citrate. Archives of Biochemistry and Biophysics. 475(1). 72–79. 16 indexed citations
9.
Cheng, Dongmei, Ching-Hsuen Chu, Luping Chen, et al.. (2006). Expression, purification, and characterization of human and rat acetyl cfenzyme A carboxylase (ACC) isozymes. Protein Expression and Purification. 51(1). 11–21. 36 indexed citations
10.
Marcinkeviciene, Jovita, Wenjun Jiang, Lisa M. Kopcho, et al.. (2001). Enoyl-ACP Reductase (FabI) of Haemophilus influenzae: Steady-State Kinetic Mechanism and Inhibition by Triclosan and Hexachlorophene. Archives of Biochemistry and Biophysics. 390(1). 101–108. 28 indexed citations
11.
Marcinkeviciene, Jovita, Wenjun Jiang, Gregory Locke, et al.. (2000). A Second Dihydroorotate Dehydrogenase (Type A) of the Human Pathogen Enterococcus faecalis: Expression, Purification, and Steady-State Kinetic Mechanism. Archives of Biochemistry and Biophysics. 377(1). 178–186. 27 indexed citations
12.
Jiang, Wenjun, Gregory Locke, Mark R. Harpel, Robert A. Copeland, & Jovita Marcinkeviciene. (2000). Role of Lys100 in Human Dihydroorotate Dehydrogenase:  Mutagenesis Studies and Chemical Rescue by External Amines. Biochemistry. 39(27). 7990–7997. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Palani Kirubakaran Breakdown of academic impact, for papers by Galina Bernstein Breakdown of academic impact, for papers by Hazel Corradi Breakdown of academic impact, for papers by Khairul Bariyyah Abd Halim Breakdown of academic impact, for papers by Adrien Herlédan Breakdown of academic impact, for papers by Jianxin Cheng Breakdown of academic impact, for papers by Alison Leed Breakdown of academic impact, for papers by V.L. Linhard Breakdown of academic impact, for papers by Giuseppe Punzi Breakdown of academic impact, for papers by Huan‐Yi Tseng
Rankless by CCL
2026